|
⚲
|
| Keyboard |
| Vertex Pharmaceuticals Inc / Ma | |
|---|---|
| Ticker | VRTX |
| CIK # | 0000875320 |
| CUSIP | 92532F100 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 130 Waverly Street, Cambridge, MA 02139-4242 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Vertex Pharmaceuticals Inc / Ma | 2009-03-18 | 2.4 M | Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0000875320] | 10-K | |
| [0000875320] | 10-Q | |
| [0000875320] | 3 | |
| [0000875320] | 4 | |
| [0000875320] | 5 | |
| [0000875320] | 8-K | |
| [0000875320] | SC 13D | |
| [0000875320] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bozic Carmen
Common Stock
|
2026-03-27 | Sell | 2,329 | $450.95 | 1,050,263 |
|
Bozic Carmen
Common Stock
|
2026-03-13 | Sell | 2,329 | $481.79 | 1,122,089 |
|
McKechnie Duncan
Common Stock
|
2026-03-11 | Sell | 2,633 | $498.42 | 1,312,340 |
|
McKechnie Duncan
Common Stock
|
2026-03-04 | Sell | 2,437 | $475.30 | 1,158,306 |
|
Liu Joy
Common Stock
|
2026-03-02 | Sell | 892 | $495.96 | 442,396 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 949 | $491.30 | 466,244 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 400 | $479.75 | 191,900 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 15,580 | $495.38 | 7,718,020 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 3,278 | $488.27 | 1,600,549 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 240 | $482.84 | 115,882 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 460 | $489.32 | 225,087 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 120 | $481.50 | 57,780 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 5,995 | $496.16 | 2,974,479 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 2,725 | $490.54 | 1,336,722 |
|
Bozic Carmen
Common Stock
|
2026-02-27 | Sell | 2,329 | $480.31 | 1,118,642 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 2,520 | $493.29 | 1,243,091 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 3,498 | $494.33 | 1,729,166 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 1,725 | $496.95 | 857,239 |
|
Kewalramani Reshma
Common Stock
|
2026-02-27 | Sell | 2,510 | $487.13 | 1,222,696 |
|
Ambrose Kristen
Common Stock
|
2026-02-26 | Sell | 357 | $483.36 | 172,560 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 1,696 | 235,407,197 |
| 2025-12-31 | 1,676 | 238,812,857 |
| 2025-09-30 | 1,528 | 234,859,647 |
| 2025-06-30 | 1,564 | 237,688,196 |
| 2025-03-31 | 1,616 | 231,920,219 |
| 2024-12-31 | 1,566 | 229,226,756 |
| 2024-09-30 | 1,552 | 234,928,156 |
| 2024-06-30 | 1,554 | 233,432,366 |
| 2024-03-31 | 1,494 | 234,606,953 |
| 2023-12-31 | 1,444 | 231,326,626 |
| 2023-09-30 | 1,280 | 220,051,416 |
| 2023-06-30 | 1,287 | 220,579,739 |